ReviewJAC-antimicrobial resistance2025
UK Parliament's antimicrobial resistance inquiry: translating evidence into crisis-resilient action.
Review in JAC-antimicrobial resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parliamentary inquiries play a crucial role in bridging scientific evidence and health policy. In response to the United Kingdom (UK) Parliament's Public Accounts Committee inquiry on antimicrobial resistance (AMR), this Viewpoint presents a 'crisis-resilient antimicrobial stewardship' model designed to sustain effectiveness during emergencies while strengthening routine performance. The model is organized around five interconnected pillars: digital innovation and diagnostics, One Health and environmental governance, workforce resilience and training, surveillance and data integration, and governance and policy alignment. Positioned within the global policy context of the World Health Organization (WHO), the European Union (EU), and the Sustainable Development Goals, it embeds equity, sustainability, and accountability. Aligning national reforms with international frameworks can enhance the UK's contribution to global AMR resilience and the 2030 Agenda.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.